Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × HER2 Positive Breast Cancer × copanlisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 7 Neoplasm Metastasis 5 Breast Neoplasms 5 Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 3 Hodgkin Disease 3 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Thrombocytosis 1 Squamous Cell Carcinoma of Head and Neck 1 Renal Insufficiency 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1

Interventions

copanlisib 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02705859 2025-01-09

Panther

Cancer Trials Ireland

Phase 1 Completed

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡